E-viri
Recenzirano
Odprti dostop
-
Zaidi, Syed H; Harrison, Tabitha A; Phipps, Amanda I; Steinfelder, Robert; Trinh, Quang M; Qu, Conghui; Banbury, Barbara L; Georgeson, Peter; Grasso, Catherine S; Giannakis, Marios; Adams, Jeremy B; Alwers, Elizabeth; Amitay, Efrat L; Barfield, Richard T; Berndt, Sonja I; Borozan, Ivan; Brenner, Hermann; Brezina, Stefanie; Buchanan, Daniel D; Cao, Yin; Chan, Andrew T; Chang-Claude, Jenny; Connolly, Charles M; Drew, David A; Farris, 3rd, Alton Brad; Figueiredo, Jane C; French, Amy J; Fuchs, Charles S; Garraway, Levi A; Gruber, Steve; Guinter, Mark A; Hamilton, Stanley R; Harlid, Sophia; Heisler, Lawrence E; Hidaka, Akihisa; Hopper, John L; Huang, Wen-Yi; Huyghe, Jeroen R; Jenkins, Mark A; Krzyzanowski, Paul M; Lemire, Mathieu; Lin, Yi; Luo, Xuemei; Mardis, Elaine R; McPherson, John D; Miller, Jessica K; Moreno, Victor; Mu, Xinmeng Jasmine; Nishihara, Reiko; Papadopoulos, Nickolas; Pasternack, Danielle; Quist, Michael J; Rafikova, Adilya; Reid, Emma E G; Shinbrot, Eve; Shirts, Brian H; Stein, Lincoln D; Teney, Cherie D; Timms, Lee; Um, Caroline Y; Van Guelpen, Bethany; Van Tassel, Megan; Wang, Xiaolong; Wheeler, David A; Yung, Christina K; Hsu, Li; Ogino, Shuji; Gsur, Andrea; Newcomb, Polly A; Gallinger, Steven; Hoffmeister, Michael; Campbell, Peter T; Thibodeau, Stephen N; Sun, Wei; Hudson, Thomas J; Peters, Ulrike
Nature communications, 07/2020, Letnik: 11, Številka: 1Journal Article
Colorectal cancer (CRC) is a biologically heterogeneous disease. To characterize its mutational profile, we conduct targeted sequencing of 205 genes for 2,105 CRC cases with survival data. Our data shows several findings in addition to enhancing the existing knowledge of CRC. We identify PRKCI, SPZ1, MUTYH, MAP2K4, FETUB, and TGFBR2 as additional genes significantly mutated in CRC. We find that among hypermutated tumors, an increased mutation burden is associated with improved CRC-specific survival (HR = 0.42, 95% CI: 0.21-0.82). Mutations in TP53 are associated with poorer CRC-specific survival, which is most pronounced in cases carrying TP53 mutations with predicted 0% transcriptional activity (HR = 1.53, 95% CI: 1.21-1.94). Furthermore, we observe differences in mutational frequency of several genes and pathways by tumor location, stage, and sex. Overall, this large study provides deep insights into somatic mutations in CRC, and their potential relationships with survival and tumor features.
Avtor
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|
Vir: Osebne bibliografije
in: SICRIS
To gradivo vam je dostopno v celotnem besedilu. Če kljub temu želite naročiti gradivo, kliknite gumb Nadaljuj.